SlideShare une entreprise Scribd logo
1  sur  5
Télécharger pour lire hors ligne
Communicating Complication Risks
from Influenza A (H1N1)
Tom´s J. Arag´n, MD, DrPH
a
o
Health Officer, City & County of San Francisco
Director, Population Health Division (PHD)
San Francisco Department of Public Health
Adjunct Faculty, Division of Epidemiology
UC Berkeley School of Public Health
Email: tomas.aragon@sfdph.org

February 7, 2014

Tom´s J. Arag´n, MD, DrPH (SFDPH)
a
o

Influenza Risk Communication

February 7, 2014

1/5
Individual risk of complication vs number of complications
For simplicity, we focus on complications (e.g., death)
Types of individual risks
Risk of complication given infectiona
Risk of complication given influenza seasonb
a
b

driven by individual susceptibility
driven by individual susceptibility and prevalence of circulating subtype

It is important to distinguish the difference between the types of individual
risk and the number of cases in a season. You can have low individual
risks but large number of cases if there are many susceptibles. However,
the large number of complications may give the perception that the
individual risks are large.
In the next slide, we use the epidemic equation to help understand the
components that go into individual risks and number of complications.
Tom´s J. Arag´n, MD, DrPH (SFDPH)
a
o

Influenza Risk Communication

February 7, 2014

2/5
Number of complications from influenza during a season
Epidemic equation
Number of complications = Pr(Complication) × NS
= c × P × p × Pr(D | I) × Pr(C | D) × NS

c = contact rate to potential infectious influenza cases
P = prevalence of influenza in the community*
p = transmission probability given contact with influenza case*
I = infection (transmission)
D = disease (symptomatic flu)**
C = complication (e.g., death)**
NS = number of susceptibles in population
* drivers for transmission of novel strains (i.e., spread)
** function of host predisposition (e.g., obesity) and novel strain virulence
Tom´s J. Arag´n, MD, DrPH (SFDPH)
a
o

Influenza Risk Communication

February 7, 2014

3/5
Components of transmission probability (p)

Infectiousness of source
Susceptibility of host
Infection control

Tom´s J. Arag´n, MD, DrPH (SFDPH)
a
o

Influenza Risk Communication

February 7, 2014

4/5
What explains increase in number of H1N1 deaths in
2013-2014 season?
Assuming no changes in the virulence of H1N1 (i.e., chance of
complication given infection), the only plausible explanation would be a
combination of the following:
Increase in circulating H1N1 (P , prevalence)
Large susceptible population (NS )
In an influenza pandemic, not everyone becomes infected with the pandemic
strain. In a non-pandemic season, the risk of infection is about 10%. This means
a large proportion of the population remained susceptible (NS ) to H1N1
assuming they did not get natural H1N1 infection (a reasonable chance), or did
not get vaccinated. Since 2009, H1N1 and H3N2 have been competing, and
which dominates will depend on available susceptibles. Finally, even with a stable
and low individual risk of complications (like H1N1), we can see many deaths if
the number of sususceptibles is large. Nonetheless, this gives the perception that
H1N1 may be worse (more virulent).
Tom´s J. Arag´n, MD, DrPH (SFDPH)
a
o

Influenza Risk Communication

February 7, 2014

5/5

Contenu connexe

Plus de Tomas J. Aragon

The Leading Population Health Framework
The Leading Population Health FrameworkThe Leading Population Health Framework
The Leading Population Health FrameworkTomas J. Aragon
 
What is population health?
What is population health?What is population health?
What is population health?Tomas J. Aragon
 
Population Health Lean (SLIDES)
Population Health Lean (SLIDES)Population Health Lean (SLIDES)
Population Health Lean (SLIDES)Tomas J. Aragon
 
Population Health Lean: An overview
Population Health Lean: An overviewPopulation Health Lean: An overview
Population Health Lean: An overviewTomas J. Aragon
 
Structural Trauma & Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma & Toxic Stress: Lifecourse Roots of Health InequitiesStructural Trauma & Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma & Toxic Stress: Lifecourse Roots of Health InequitiesTomas J. Aragon
 
Structural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma and Toxic Stress: Lifecourse Roots of Health InequitiesStructural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma and Toxic Stress: Lifecourse Roots of Health InequitiesTomas J. Aragon
 
Structural Trauma and Toxic Stress! Inter-generational Roots of Adults Health...
Structural Trauma and Toxic Stress! Inter-generational Roots of Adults Health...Structural Trauma and Toxic Stress! Inter-generational Roots of Adults Health...
Structural Trauma and Toxic Stress! Inter-generational Roots of Adults Health...Tomas J. Aragon
 
What is collective impact?
What is collective impact?What is collective impact?
What is collective impact?Tomas J. Aragon
 
Leading population health---A results-based lean approach
Leading population health---A results-based lean approachLeading population health---A results-based lean approach
Leading population health---A results-based lean approachTomas J. Aragon
 
Population Health Data Science, Complexity, and Health Equity: Reflections fr...
Population Health Data Science, Complexity, and Health Equity: Reflections fr...Population Health Data Science, Complexity, and Health Equity: Reflections fr...
Population Health Data Science, Complexity, and Health Equity: Reflections fr...Tomas J. Aragon
 
Toxic Stress! Childhood Roots of Health Inequities:
Toxic Stress! Childhood Roots of Health Inequities:Toxic Stress! Childhood Roots of Health Inequities:
Toxic Stress! Childhood Roots of Health Inequities:Tomas J. Aragon
 
Continuous Decision Improvement: Decisive Leadership for Complex Environments
Continuous Decision Improvement: Decisive Leadership for Complex EnvironmentsContinuous Decision Improvement: Decisive Leadership for Complex Environments
Continuous Decision Improvement: Decisive Leadership for Complex EnvironmentsTomas J. Aragon
 
Continuous Decision Improvement (CDI): Public Health Decision Making for Comp...
Continuous Decision Improvement (CDI): Public Health Decision Making for Comp...Continuous Decision Improvement (CDI): Public Health Decision Making for Comp...
Continuous Decision Improvement (CDI): Public Health Decision Making for Comp...Tomas J. Aragon
 
POSTER: Designing Learning Health Organization for Collective Impact Using REACH
POSTER: Designing Learning Health Organization for Collective Impact Using REACHPOSTER: Designing Learning Health Organization for Collective Impact Using REACH
POSTER: Designing Learning Health Organization for Collective Impact Using REACHTomas J. Aragon
 
Designing a Learning Health Organization for Collective Impact
Designing a Learning Health Organization for Collective ImpactDesigning a Learning Health Organization for Collective Impact
Designing a Learning Health Organization for Collective ImpactTomas J. Aragon
 
Understanding R for Epidemiologists
Understanding R for EpidemiologistsUnderstanding R for Epidemiologists
Understanding R for EpidemiologistsTomas J. Aragon
 
Curriculum vitae (LaTeX PDF)
Curriculum vitae (LaTeX PDF)Curriculum vitae (LaTeX PDF)
Curriculum vitae (LaTeX PDF)Tomas J. Aragon
 
The High Achieving Governmental Health Department in 2020 as the Community Ch...
The High Achieving Governmental Health Department in 2020 as the Community Ch...The High Achieving Governmental Health Department in 2020 as the Community Ch...
The High Achieving Governmental Health Department in 2020 as the Community Ch...Tomas J. Aragon
 
Preparing for Microbial Threats to Health: What Every Professional Should Know
Preparing for Microbial Threats to Health: What Every Professional Should KnowPreparing for Microbial Threats to Health: What Every Professional Should Know
Preparing for Microbial Threats to Health: What Every Professional Should KnowTomas J. Aragon
 

Plus de Tomas J. Aragon (20)

The Leading Population Health Framework
The Leading Population Health FrameworkThe Leading Population Health Framework
The Leading Population Health Framework
 
What is population health?
What is population health?What is population health?
What is population health?
 
PDSA Problem-Solving
PDSA Problem-SolvingPDSA Problem-Solving
PDSA Problem-Solving
 
Population Health Lean (SLIDES)
Population Health Lean (SLIDES)Population Health Lean (SLIDES)
Population Health Lean (SLIDES)
 
Population Health Lean: An overview
Population Health Lean: An overviewPopulation Health Lean: An overview
Population Health Lean: An overview
 
Structural Trauma & Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma & Toxic Stress: Lifecourse Roots of Health InequitiesStructural Trauma & Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma & Toxic Stress: Lifecourse Roots of Health Inequities
 
Structural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma and Toxic Stress: Lifecourse Roots of Health InequitiesStructural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
 
Structural Trauma and Toxic Stress! Inter-generational Roots of Adults Health...
Structural Trauma and Toxic Stress! Inter-generational Roots of Adults Health...Structural Trauma and Toxic Stress! Inter-generational Roots of Adults Health...
Structural Trauma and Toxic Stress! Inter-generational Roots of Adults Health...
 
What is collective impact?
What is collective impact?What is collective impact?
What is collective impact?
 
Leading population health---A results-based lean approach
Leading population health---A results-based lean approachLeading population health---A results-based lean approach
Leading population health---A results-based lean approach
 
Population Health Data Science, Complexity, and Health Equity: Reflections fr...
Population Health Data Science, Complexity, and Health Equity: Reflections fr...Population Health Data Science, Complexity, and Health Equity: Reflections fr...
Population Health Data Science, Complexity, and Health Equity: Reflections fr...
 
Toxic Stress! Childhood Roots of Health Inequities:
Toxic Stress! Childhood Roots of Health Inequities:Toxic Stress! Childhood Roots of Health Inequities:
Toxic Stress! Childhood Roots of Health Inequities:
 
Continuous Decision Improvement: Decisive Leadership for Complex Environments
Continuous Decision Improvement: Decisive Leadership for Complex EnvironmentsContinuous Decision Improvement: Decisive Leadership for Complex Environments
Continuous Decision Improvement: Decisive Leadership for Complex Environments
 
Continuous Decision Improvement (CDI): Public Health Decision Making for Comp...
Continuous Decision Improvement (CDI): Public Health Decision Making for Comp...Continuous Decision Improvement (CDI): Public Health Decision Making for Comp...
Continuous Decision Improvement (CDI): Public Health Decision Making for Comp...
 
POSTER: Designing Learning Health Organization for Collective Impact Using REACH
POSTER: Designing Learning Health Organization for Collective Impact Using REACHPOSTER: Designing Learning Health Organization for Collective Impact Using REACH
POSTER: Designing Learning Health Organization for Collective Impact Using REACH
 
Designing a Learning Health Organization for Collective Impact
Designing a Learning Health Organization for Collective ImpactDesigning a Learning Health Organization for Collective Impact
Designing a Learning Health Organization for Collective Impact
 
Understanding R for Epidemiologists
Understanding R for EpidemiologistsUnderstanding R for Epidemiologists
Understanding R for Epidemiologists
 
Curriculum vitae (LaTeX PDF)
Curriculum vitae (LaTeX PDF)Curriculum vitae (LaTeX PDF)
Curriculum vitae (LaTeX PDF)
 
The High Achieving Governmental Health Department in 2020 as the Community Ch...
The High Achieving Governmental Health Department in 2020 as the Community Ch...The High Achieving Governmental Health Department in 2020 as the Community Ch...
The High Achieving Governmental Health Department in 2020 as the Community Ch...
 
Preparing for Microbial Threats to Health: What Every Professional Should Know
Preparing for Microbial Threats to Health: What Every Professional Should KnowPreparing for Microbial Threats to Health: What Every Professional Should Know
Preparing for Microbial Threats to Health: What Every Professional Should Know
 

Dernier

LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 

Dernier (20)

LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 

Communicating Complication Risks from Influenza A (H1N1)

  • 1. Communicating Complication Risks from Influenza A (H1N1) Tom´s J. Arag´n, MD, DrPH a o Health Officer, City & County of San Francisco Director, Population Health Division (PHD) San Francisco Department of Public Health Adjunct Faculty, Division of Epidemiology UC Berkeley School of Public Health Email: tomas.aragon@sfdph.org February 7, 2014 Tom´s J. Arag´n, MD, DrPH (SFDPH) a o Influenza Risk Communication February 7, 2014 1/5
  • 2. Individual risk of complication vs number of complications For simplicity, we focus on complications (e.g., death) Types of individual risks Risk of complication given infectiona Risk of complication given influenza seasonb a b driven by individual susceptibility driven by individual susceptibility and prevalence of circulating subtype It is important to distinguish the difference between the types of individual risk and the number of cases in a season. You can have low individual risks but large number of cases if there are many susceptibles. However, the large number of complications may give the perception that the individual risks are large. In the next slide, we use the epidemic equation to help understand the components that go into individual risks and number of complications. Tom´s J. Arag´n, MD, DrPH (SFDPH) a o Influenza Risk Communication February 7, 2014 2/5
  • 3. Number of complications from influenza during a season Epidemic equation Number of complications = Pr(Complication) × NS = c × P × p × Pr(D | I) × Pr(C | D) × NS c = contact rate to potential infectious influenza cases P = prevalence of influenza in the community* p = transmission probability given contact with influenza case* I = infection (transmission) D = disease (symptomatic flu)** C = complication (e.g., death)** NS = number of susceptibles in population * drivers for transmission of novel strains (i.e., spread) ** function of host predisposition (e.g., obesity) and novel strain virulence Tom´s J. Arag´n, MD, DrPH (SFDPH) a o Influenza Risk Communication February 7, 2014 3/5
  • 4. Components of transmission probability (p) Infectiousness of source Susceptibility of host Infection control Tom´s J. Arag´n, MD, DrPH (SFDPH) a o Influenza Risk Communication February 7, 2014 4/5
  • 5. What explains increase in number of H1N1 deaths in 2013-2014 season? Assuming no changes in the virulence of H1N1 (i.e., chance of complication given infection), the only plausible explanation would be a combination of the following: Increase in circulating H1N1 (P , prevalence) Large susceptible population (NS ) In an influenza pandemic, not everyone becomes infected with the pandemic strain. In a non-pandemic season, the risk of infection is about 10%. This means a large proportion of the population remained susceptible (NS ) to H1N1 assuming they did not get natural H1N1 infection (a reasonable chance), or did not get vaccinated. Since 2009, H1N1 and H3N2 have been competing, and which dominates will depend on available susceptibles. Finally, even with a stable and low individual risk of complications (like H1N1), we can see many deaths if the number of sususceptibles is large. Nonetheless, this gives the perception that H1N1 may be worse (more virulent). Tom´s J. Arag´n, MD, DrPH (SFDPH) a o Influenza Risk Communication February 7, 2014 5/5